share_log

HC Wainwright & Co. Maintains Buy on Axsome Therapeutics, Maintains $190 Price Target

Moomoo 24/7 ·  Apr 2 08:53

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Axsome Therapeutics (NASDAQ:AXSM) with a Buy and maintains $190 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment